EpCAM has been popularly used for targeting tumor cells circulating in the bloodstream; however, it has been shown that there are CTCs devoid of EpCAM expression, as well as non-CTCs expressing EpCAM in the blood of cancer patients [232]. Here, EPCAM is linked to neoplasm.